跳至主要内容
临床试验/JPRN-UMIN000009519
JPRN-UMIN000009519已完成未知

Comparison study among FM/BUD(Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB(Salbutamol) about bronchodilating effect part and onset of relief of dyspnea. - Comparison study among FM/BUD(Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB(salbutamol)about bronchodilating effect part and onset of relief of dyspnea.

Juntendo University0 个研究点目标入组 11 人开始时间: 2013年1月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
11

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 40years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Aortic aneurysm 2.Pregnancy 3.History of cerebral infarction within three months. 4.Breast-feeding women 5.Hypertension 6.Diabetes mellitus 7.Hyperthyroidism 8.Cardiac disease

研究者

相似试验

尚未招募
不适用
To study effect of Vitamin D supplementation in asthma patients
CTRI/2021/09/036165Dr Preeti Navik
已完成
不适用
Effects of budesonide and formoterol combination on airway regulatory T cells in mild asthmatics
JPRN-UMIN000004275Division of respirology, neurology, and rheumatology, Department of medicine, Kurume University School of Medicine10
已完成
不适用
Study on the effects of the budesonide/formoterol combination formulation in improving airway inflammation and airway resistance in patients with bronchial asthmaPatients with bronchial asthma aged 20 years and older (males and females, outpatients and inpatients) being treated with an ICS (at a dose equivalent to FP 200-1000 mcg/day) and salmeterol 100 mcg/day in combination (either as two separate products or one combined product) for 3 months or longer with poor or inadequate control
JPRN-UMIN000006572Chiba-Hokusoh Hospital, Nippon Medical School80
已完成
不适用
Budesonide/formoterol combination therapy versus budesonide plus tulobuterol-patch therapy in elderly asthmatic patients: A randomized, comparative studyBronchial Asthma
JPRN-UMIN000006551Second Department of Internal Medicine, Nagasaki University Hospital50
已完成
不适用
Improved effects of Budesonide/Formoterol combination therapy (Symbicort) on the residual eosinophilic inflammation in the distal airways of asthmatic patients who used the salmeterol/fluticasone combination drugBronchial asthma
JPRN-UMIN000003805JA Tohno Kousei Hospital40